Lifemd Inc Stock Performance
| LFMD Stock | USD 3.50 0.02 0.57% |
The company secures a Beta (Market Risk) of 3.04, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, LifeMD will likely underperform. At this point, LifeMD Inc has a negative expected return of -0.71%. Please make sure to verify LifeMD's total risk alpha, kurtosis, price action indicator, as well as the relationship between the value at risk and rate of daily change , to decide if LifeMD Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days LifeMD Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in February 2026. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return (0.57) | Five Day Return (3.05) | Year To Date Return 0.29 | Ten Year Return 337.5 | All Time Return 1.6 K |
Last Split Factor 1:5 | Dividend Date 2020-10-14 | Last Split Date 2020-10-14 |
1 | DEADLINE ALERT Faruqi Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD | 10/29/2025 |
2 | LifeMD to Offer Market-Leading Pricing for GLP-1 Medications Wegovy and Ozempic in Continued Collaboration with Novo Nordisk | 11/17/2025 |
3 | Lake Street Capital Cuts LifeMD Price Target to 8.00 | 11/21/2025 |
4 | LifeMD Recognized by the 2025 Deloitte Technology Fast 500 and by TIMEs Americas Growth Leaders of 2026 | 11/24/2025 |
5 | Disposition of 15000 shares by Jessica Friedeman of LifeMD at 3.6105 subject to Rule 16b-3 | 12/09/2025 |
6 | LifeMD stock price target lowered to 8 at Lake Street on weight management headwinds - Investing.com | 12/26/2025 |
7 | LifeMD, Inc. Given Consensus Recommendation of Moderate Buy by Analysts - MarketBeat | 12/31/2025 |
8 | symbol Stock Quote Price and Forecast - CNN | 01/07/2026 |
| Begin Period Cash Flow | 33.1 M | |
| Total Cashflows From Investing Activities | -11.5 M |
LifeMD Relative Risk vs. Return Landscape
If you would invest 580.00 in LifeMD Inc on October 30, 2025 and sell it today you would lose (230.00) from holding LifeMD Inc or give up 39.66% of portfolio value over 90 days. LifeMD Inc is currently does not generate positive expected returns and assumes 5.1104% risk (volatility on return distribution) over the 90 days horizon. In different words, 45% of stocks are less volatile than LifeMD, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
LifeMD Target Price Odds to finish over Current Price
The tendency of LifeMD Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.50 | 90 days | 3.50 | about 77.5 |
Based on a normal probability distribution, the odds of LifeMD to move above the current price in 90 days from now is about 77.5 (This LifeMD Inc probability density function shows the probability of LifeMD Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 3.04 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, LifeMD will likely underperform. Additionally LifeMD Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. LifeMD Price Density |
| Price |
Predictive Modules for LifeMD
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as LifeMD Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.LifeMD Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. LifeMD is not an exception. The market had few large corrections towards the LifeMD's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold LifeMD Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of LifeMD within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.95 | |
β | Beta against Dow Jones | 3.04 | |
σ | Overall volatility | 0.94 | |
Ir | Information ratio | -0.16 |
LifeMD Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of LifeMD for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for LifeMD Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| LifeMD Inc generated a negative expected return over the last 90 days | |
| LifeMD Inc has high historical volatility and very poor performance | |
| LifeMD Inc has high likelihood to experience some financial distress in the next 2 years | |
| LifeMD Inc currently holds 25.1 M in liabilities with Debt to Equity (D/E) ratio of 0.46, which is about average as compared to similar companies. LifeMD Inc has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about LifeMD's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 212.45 M. Net Loss for the year was (18.73 M) with profit before overhead, payroll, taxes, and interest of 217.18 M. | |
| About 15.0% of LifeMD outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Disposition of 11794 shares by Leslie Trigg of Outset Medical at 5.12 subject to Rule 16b-3 |
LifeMD Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of LifeMD Stock often depends not only on the future outlook of the current and potential LifeMD's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LifeMD's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 41.2 M | |
| Cash And Short Term Investments | 35 M |
LifeMD Fundamentals Growth
LifeMD Stock prices reflect investors' perceptions of the future prospects and financial health of LifeMD, and LifeMD fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LifeMD Stock performance.
| Return On Equity | -22.43 | ||||
| Return On Asset | -0.0285 | ||||
| Profit Margin | (0.03) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 152.18 M | ||||
| Shares Outstanding | 48.14 M | ||||
| Price To Book | 128.93 X | ||||
| Price To Sales | 0.68 X | ||||
| Revenue | 212.45 M | ||||
| Gross Profit | 217.18 M | ||||
| EBITDA | (6.65 M) | ||||
| Net Income | (18.73 M) | ||||
| Cash And Equivalents | 5.84 M | ||||
| Cash Per Share | 0.19 X | ||||
| Total Debt | 25.1 M | ||||
| Debt To Equity | 0.46 % | ||||
| Current Ratio | 0.52 X | ||||
| Book Value Per Share | 0.03 X | ||||
| Cash Flow From Operations | 17.51 M | ||||
| Earnings Per Share | (0.25) X | ||||
| Market Capitalization | 169.44 M | ||||
| Total Asset | 72.46 M | ||||
| Retained Earnings | (236.25 M) | ||||
| Working Capital | (11.52 M) | ||||
About LifeMD Performance
By analyzing LifeMD's fundamental ratios, stakeholders can gain valuable insights into LifeMD's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if LifeMD has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if LifeMD has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 48.79 | 46.35 | |
| Return On Tangible Assets | (0.38) | (0.40) | |
| Return On Capital Employed | (1.19) | (1.13) | |
| Return On Assets | (0.23) | (0.25) | |
| Return On Equity | 3.96 | 4.16 |
Things to note about LifeMD Inc performance evaluation
Checking the ongoing alerts about LifeMD for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LifeMD Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| LifeMD Inc generated a negative expected return over the last 90 days | |
| LifeMD Inc has high historical volatility and very poor performance | |
| LifeMD Inc has high likelihood to experience some financial distress in the next 2 years | |
| LifeMD Inc currently holds 25.1 M in liabilities with Debt to Equity (D/E) ratio of 0.46, which is about average as compared to similar companies. LifeMD Inc has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about LifeMD's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 212.45 M. Net Loss for the year was (18.73 M) with profit before overhead, payroll, taxes, and interest of 217.18 M. | |
| About 15.0% of LifeMD outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Disposition of 11794 shares by Leslie Trigg of Outset Medical at 5.12 subject to Rule 16b-3 |
- Analyzing LifeMD's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LifeMD's stock is overvalued or undervalued compared to its peers.
- Examining LifeMD's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating LifeMD's management team can have a significant impact on its success or failure. Reviewing the track record and experience of LifeMD's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of LifeMD's stock. These opinions can provide insight into LifeMD's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for LifeMD Stock analysis
When running LifeMD's price analysis, check to measure LifeMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LifeMD is operating at the current time. Most of LifeMD's value examination focuses on studying past and present price action to predict the probability of LifeMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LifeMD's price. Additionally, you may evaluate how the addition of LifeMD to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |